Where tomorrow lives.

Imagine a tomorrow where experiencing and appreciating what life has to offer is a daily occurrence.  More weddings, more sunsets, more laughter, and most importantly, more living.

With uncompromising dedication and a spirit of innovation born from a sense of compassion, we strive for bold diagnostic solutions that may lead to better outcomes for patients across their journeys.

At Oncocyte™, we focus on tomorrow to help deliver better cancer care today.

Products

Our mission is to develop a family of tests to provide physicians and their patients actionable answers at critical decision points across the cancer care continuum.

READ MORE

Rx

DetermaRx

A treatment stratification test for early-stage lung cancer

Learn More

IO

DetermaIO

(for research use only)

A novel multivariate gene expression test to
identify immune checkpoint inhibitor responders

Learn More

Dx

DetermaDx

(in development)

A liquid biopsy test to rule out malignancy in lung nodules

Learn More

About Us

At Oncocyte, we believe that empowering physicians with bold and innovative diagnostic solutions may lead to better outcomes for their patients.

READ MORE

Investors

Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers at critical decision points across the lung cancer care continuum, with the goal of improving patient outcomes by accelerating and optimizing diagnosis and treatment.

READ MORE